The Association between Neutrophil to Lymphocyte Ratio and Demographic and Clinical Data in Diabetic Peripheral Neuropathy Patients in Jeddah
Journal of Pharmaceutical Research International, Volume 34, Issue 60,
Introduction: Diabetes mellitus (DM) is a major chronic systemic health concern that could develop macro- and microvascular complications. One of the commonest microvascular complications is diabetic peripheral neuropathy (DPN) which is a type of nerve damage caused by uncontrolled hyperglycemia of diabetic patients. DPN is one of the most common causes of reduction in life quality and disability in DM patients, as well as; it overload the national health care system. Finding a cost-effective, easy prognostic marker to early detect DPN could be an important step in prevention DM complications. Our research aimed to assess the association between neutrophil to lymphocyte ratio and demographic and clinical data in diabetic neuropathy patients with average age of 60 years.
Methodology: A retrospective study was conducted on 133 patients by reviewing the data records over the period of 10 years from January 2012 to July 2022. The study was done at king Abdul-Aziz University Hospital, Jeddah, in the western region of KSA amongst diabetic peripheral neuropathy patients who are using either oral hypoglycemic agents or insulin with regular follow ups.
Results: The study included a total of 133 patients with most of them being male i.e., 81 (61%). The mean age of the patients was 60(SD13.5) years. Approximately two-third of the patients 86(64.7%) had diabetes for more than 10 years. There was no significant association identified for gender, age group, nationality, and medication (p >0.05) with HbA1c or NLR. Moreover, there was no significant association between NLR and HbA1c categories.
Conclusion: In conclusion our study showed non-significant relationship between NLR and DPN among elderly diabetic patient at King Abdu al-aziz university hospital (KAUH).
- Type 2 diabetes
- antidiabetic medications
- neutrophil to lymphocyte ratio (NLR)
- peripheral neuropathy
How to Cite
Cuma Mertoglu, Murat Gunay. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2017; 11:S127–31.
David R, Whiting, others. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice. 2011; 94(3):311–21 Available:https://doi.org/10.1016/j.diabres.2011.10.029.
James Bentham and others. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128•9 million children, adolescents, and adults. The Lancet. 2017;390(10113): 2627–42.
Linda Tran and others. Pharmacologic treatment of type 2 diabetes: oral medications. Annals of Pharmacotherapy. 2015;49(5):540–56.
Yan Zheng, Sylvia H. Ley, Frank B. Hu. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology. 2018; 14(2):88–98
Basel Alzahrani and others. Prevalence and risk factors for diabetic nephropathy in type 2 diabetic patients, Taif City, Saudi Arabia. International Journal of Medicine in Developing Countries. 2019;167–72.
Mark Davies and others. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–22.
Cameron NE and others. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia. 2001;44(11): 1973–88.
N Janahi. The role of pro -inflammatoy cytokines and autoimmune antibodies in diabetic peripheral neuropathy. Noor Janahi a thesis submitted in partial fulfilment of the requirements for the degree of professional doctorate of health and social sciences. 2014;287.
Tesfaye S and others. Vascular risk factors and diabetic neuropathy' N Engl J Med. 2005;352:341–350.
Kampoli AM, and others. Otential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus. Curr Pharm Des. 2011;17:4147–4158.
Cho H and others. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009;58:15–23.
Bhat T and others. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11:55–59.
Huang W and others. Neutrophil-lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clin Endocrinol (Oxf). 2015; 82:229–233.
Luo P and others. The relationship between neutrophil-to-lymphocyte ratio and intracerebral hemorrhage in type 2 diabetes mellitus. J Stroke Cerebrovasc Dis. 2017;26:930–937.
Yuan ZY and others. Prognostic value of preoperative neutrophil-lymphocyte ratio is superior to platelet-lymphocyte ratio for survival in patients who underwent complete resection of thymic carcinoma. J Thorac Dis. 2016;8:1487.
Kultigin Turkmen and others. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Renal Failure. 2012;34(2):155–59.
Sevket Balta, Turgay Celik, and others. The relation between atherosclerosis and the neutrophillymphocyte ratio. Clinical and Applied Thrombosis/Hemostasis. 2016;22(5):405–11
Walsh SR and others. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. Journal of Surgical Oncology. 2005;91(3):181–84.
Mazhar Hussain and others. Neutrophil lymphocyte ratio (NLR): a well assessment tool of glycemic control in type-2 diabetic patients. Pakistan Journal of Medical Sciences. 2017;33(6):1366–70.
Korean Diabetes Association. Treatment guideline for diabetes. J Korean Diabetes. 2015;12:S109–S112.
Tuna Demirdal, Pinar Sen. The significance of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and lymphocyte-monocyte ratio in predicting peripheral arterial disease, peripheral neuropathy, osteomyelitis and amputation in diabetic foot infection. Diabetes Research and Clinical Practice. 2018;144:118–25.
Fauzia Imtiaz and others. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in asian population. International Archives of Medicine. 2012;5(1):2.
Sevket Balta, Ertugrul Kurtoglu, and others. Neutrophil-lymphocyte ratio as an important assessment tool. Expert Review of Cardiovascular Therapy. 2014;12(5): 537–38.
Sagar Ashokrao Khandare and others. Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes. Indian Journal of Endocrinology and Metabolism. 2017; 21(3):387–92.
Lee GK and others. The long-term predictive value of the neutrophil-to-lymphocyte ratio in type 2 diabetic patients presenting with acute myocardial infarction. Qjm. 2012;105(11):1075–82.
Siying Liu and others. Neutrophil-to-lymphocyte ratio is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Research and Clinical Practice. 2017; 130:90–97.
Pace NP and others. Association between neutrophil-lymphocyte ratio and gestational diabetes-a systematic review and meta-analysis. J Endocr Soc. 2021;5(7):bvab051.
Luo WJ and others. The relationship of blood cell-associated inflammatory indices and diabetic retinopathy: a Meta-analysis and systematic review. Int J Ophthalmol. 2019;12(2):312-323.
Meiqin Lou and others. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocrine Disorders. 2015;15(1):4–9.
Mertoglu C, Gunay M. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2017;11(Suppl 1):S127-S131.
DOI: 10.1016/j.dsx.2016.12.021. Epub 2016 Dec 12. PMID: 28017281.
Fatima Ali and others. White blood cell subpopulation changes and prevalence of neutropenia among arab diabetic patients attending dasman diabetes institute in Kuwait. PLoS ONE. 2018;13(3):1–12.
Abstract View: 99 times
PDF Download: 21 times